Sentences with phrase «programs in other states»

Begun in 1993, this program currently is the subject of two rigorously designed outcome studies and has stimulated research and development of similar programs in other states.11

«CFACT was able to convince school board leaders in the state that students deserve to learn all the facts and are smart enough to weigh alternative explanations,» he said, noting that this initiative would «serve as a model for similar programs in other states.»

SB 1208 (Wexton) and HB 2112 (Keam and Villanueva), modeled on programs in other states, had the backing of the Distributed Solar Collaborative, a stakeholder group composed of everyone but utilities.

That program may offer state tax or other benefits to residents of that state that may not be available to investors in programs in other states.

Adam Peshek, with the Florida - based Foundation for Excellence in Education, said participants in similar programs in other states typically are in attendance zones of low - performing schools and schools with a history of violence.

The eligibility requirements for ESA programs in other states are more restrictive.

If the Education Savings Account (ESA) program proposed in Senate Bill 193 becomes law, school district operating budgets can be expected to decline on average by a mere 0.14 percent in the program's first year, leaving districts with 99.86 percent of their operating budgets intact, based on the performance of school choice programs in other states.

Here's how many low - income families are participating in similar programs in other states.

On top of the flexibility created by last year's alternative certification law, CSP's bill would give charters where at least half of students are impoverished the ability to hire teachers who are licensed in other states and those who have completed alternative licensure programs in other states and taught for at least two years in high - poverty schools.

The amount of money parents receive through Alabama's credit is less than the average funding parents receive through private school choice programs in other states.

Alabama's tax - credit scholarship program has a low cap ($ 25 million) relative to similar tax - credit scholarship programs in other states.

[8] There is also similar work on training programs in other states: Florida, [9] Louisiana, [10] North Carolina, [11] and Washington.

Scholarship tax credits would expand educational opportunities for Idaho families, building on long - standing state policies encouraging private investments in education, as well as successful school choice programs in other states.

The CATO Institute has already weighed in, saying that the bill would «do a better job» than similar school choice programs in other states.

Vouchers in Wisconsin and choice programs in other states make parents the masters of their own destiny and agents in their own kids» development.

But five years later, as comptroller, he said the program was much less effective at cleaning up polluted sites than programs in other states that offered far fewer incentives.

Cuomo's medical marijuana plan will be enacted by executive order, not legislation, and will be more restrictive than programs in some other states like California.

A spokesman for State Senate Majority Leader John Flanagan (R - East Northport) said Friday that the majority is open to the concept of paid family leave and reviewing programs in other states.

Cuomo's medical marijuana plan will be enacted by administratively, not through legislation, and will be more restrictive than programs in some other states like California.

And is Meyer doing any better against top programs in other states than coaches of those programs are doing against him in his state?

Paladino advocated closing Medicaid and other public service programs to illlegal immigrants, saying thet can «go someplace else and try to get on those programs in some other state.»

However, data regarding the retention rates among loan recipients were not provided in the state's ESSA plan.40 Nebraska officials should study and publish these data and make these findings available to policymakers and education stakeholders, particularly those seeking to implement a similar program in other states experiencing similar retention issues.

Those that wish to apply, as with this program in other states, must be either a state or federal public defender.

If it works well here in Wellington and the rest of Florida they will consider offering this program in some other states.

Not exact matches

Based in Carlsbad, California, Jazzercise's instructors teach its total - body conditioning program to almost half a million participants each year in the United States and more than 30 other countries.

ENJOINED AND RESTRAINED from, in any manner or by any means, removing individuals with refugee applications approved by U.S. Citizenship and Immigration Services as part of the U.S. Refugee Admissions Program, holders of valid immigrant and non-immigrant visas, and other individuals from Iraq, Syria, Iran, Sudan, Libya, Somalia, and Yemen legally authorized to enter the United States.

Other than making vague promises to place more police officers on the streets, encouraging DNA testing for death - row inmates and calling for the need to reduce recidivism by investing in «proven community - based law - enforcement programs,» the Democrats» policy solutions over the past eight years have done little to dismantle the carceral state that they helped create.

Andrew Batholomaeus, a consultant toxicologist at Australia's University of Canberra and the University of Queensland, states that «the potential human health consequences of discouraging the use of pyriproxyfen in drinking water storage and other mosquito - reduction programs is catastrophic with potential deaths and serious disease from otherwise avoidable malaria, dengue and other mosquito - borne diseases numbered in at least the hundreds of thousands.»

Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long - Term Services and Supports (LTSS), in addition to other state - sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as «Part D»), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans AffState Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long - Term Services and Supports (LTSS), in addition to other state - sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as «Part D»), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans Affstate - sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as «Part D»), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans Affairs.

Weld had high favorability ratings from state businesses during his two terms as governor of Massachusetts in the 1990s, for cutting taxes and pushing welfare recipients into work programs, among other things.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Across the country, other states have been experimenting with similar programs to keep low - income working parents from falling off the child care cliff, in keeping with the recommendations in the Child Care and Development Block Grant Act passed in 2014.

We are one of a limited number of partners under the Apple Premium Reseller and Apple Authorized Resellers Mono - Brand programs in Latin America and the United States and aims to expand into other countries shortly.

A total of 138 public libraries and other locations in seven states — Alaska, Florida, Iowa, Kentucky, Ohio, Pennsylvania, Wyoming — and the District of Columbia took part in the 2017 DASH for the STASH investor education and protection program and contest conducted by the Investor Protection Institute (IPI) and state securities agencies.

The DASH for the STASH multi-state program is an investor education and protection poster contest that takes place as part of April's Financial Literacy Month in public libraries and other venues in participating States.

The DASH for the STASH multi-state program is an investor education and protection poster contest that takes place as part of April's Financial Literacy Month in public libraries and other venues in participating states.

The IPT works with State Securities Regulators and other partners to bring investor education and protection programs directly to Americans in their communities through the Investor Education in Your Community ® program.

IPT works with State Securities Regulators and other partners to bring investor education and protection programs directly to Americans in their communities through the Investor Education in Your Community ® program.

Public libraries and other institutions in the District of Columbia and five states — Connecticut, Illinois, Iowa, Missouri, and Nebraska — will participate in the DASH for the STASH investor education / protection program and contest taking place April 15 - May 15, 2015 as part of Financial Literacy Month.

Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long - Term Services (LTSS), in addition to other state - sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as «Part D»), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans AffState Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long - Term Services (LTSS), in addition to other state - sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as «Part D»), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans Affstate - sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as «Part D»), dual eligible programs and programs with the U.S. Department of Defense and U.S. Department of Veterans Affairs.

Connecticut's Green Bank is a widely praised program, and a public bank campaign in Vermont fell short of establishing a true public bank but led to the establishment of a loan program, funded through state reserves, for energy investments, weatherization, and other local projects.

It also stated that it would restrain the growth in direct program expenses — total program expenses excluding major transfers to persons and other levels of government — but achieving this target would be dependent on economic developments.

The Office of Investor Education carries out the SEC's investor education program, which includes producing and distributing educational materials, participating in educational seminars and investor - oriented events, and partnering with federal agencies, state regulators, and others on investor literacy initiatives.

Though net metering fights have already spread to utilities in other states, such as Colorado and Idaho, some utilities are embracing rooftop solar through new programs and utility services.

The Enrollment Program also authorizes a superior court to have jurisdiction over enrollees by allowing it to «appoint a receiver, monitor, conservator, or other designated fiduciary or officer of the court for a defendant or the defendant's assets,» as well as authorizes the Commissioner of Business Oversight to «include in civil actions claims for ancillary relief, including restitution and disgorgement, on behalf of a person injured, as well as attorney's fees and costs, and civil penalties of up to $ 25,000» for up to four years after the purported violation occurred and «refer evidence regarding violations of the bill's provisions to the Attorney General, the Financial Crimes Enforcement Network of the United States Department of the Treasury, or the district attorney of the county in which the violation occurred, who would be authorized, with or without this type of a reference, to institute appropriate proceedings.»

In addition to Mr. Levitt, the other founding members of the Advisory Board are: Charles A. Bowsher, Comptroller General of the United States and head of the General Accounting Office (GAO) for 15 years; and Professor Lucian Bebchuk, a Director of the Harvard Law School's Program on Corporate Governance.

Against that background, one might justifiably ask whether it makes sense to have one economy (the United States) in a tightening monetary policy cycle, while the other (eurozone) presses on with its more accommodative easing program.

If you are not a taxpayer of the state offering the plan, consider before investing whether your or the designated beneficiary's home state offers any state tax or other benefits that are only available for investments in such state's qualified tuition program.

You should read the disclosure document carefully before investing and consider whether your, or the beneficiary's, home state offers any state tax or other benefits that are only available for investments in its qualified tuition program.

Federal Communications Commission, Submission by the Communications Committee of the United States Catholic Conference and Others in the Matter of Amendment of the Commission's Rules Concerning Program Definitions for Commercial Broadcast Stations, BC Docket No. 78 - 355, RM - 2709, 1979, Table II.